The effect of cerium oxide on erythrocyte deformability in ischemia-reperfusion injury in rats administered sevoflurane

被引:0
作者
Turicay, Aydin [1 ]
Sivgin, Volkan [2 ]
Comu, Faruk Metin [3 ]
Kucuk, Aysegul [4 ]
Ozdemirkan, Aycan [2 ]
Gunes, Isin [5 ]
Arslan, Mustafa [2 ]
机构
[1] Erciyes Univ, Med Fac, Dept Cardiovasc Surg, Kayseri, Turkey
[2] Gazi Univ, Med Fac, Dept Anesthesiol & Reanimat, TR-06510 Ankara, Turkey
[3] Kirikkale Univ, Med Fac, Dept Physiol, Kirikkale, Turkey
[4] Kutahya Hlth Sci Univ, Med Fac, Dept Physiol, Kutahya, Turkey
[5] Erciyes Univ, Med Fac, Dept Anesthesiol & Reanimat, Kayseri, Turkey
来源
ANNALS OF CLINICAL AND ANALYTICAL MEDICINE | 2022年 / 13卷 / 12期
关键词
Ischemia-Reperfusion; Cerium Oxide; Sevoflurane; Erythrocyte Deformability; Rat; SKELETAL-MUSCLE; ANESTHESIA; NANOPARTICLES; MECHANISMS; PROPOFOL; MODEL;
D O I
10.4328/ACAM.21301
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: Ischemia-reperfusion (IR) injury is a common problem in vascular surgery. Acute IR damage observed in the lower extremities, especially in aortic surgery, occurs following temporary cross-clamping of the abdominal aorta. Disruption in blood rheology disrupts microvascular blood flow, leading to exacerbation of microangiopathy. It is known that drugs used for anesthesia affect blood rheology, which is affected by many factors. Therefore, we aimed to investigate the effects of cerium oxide on erythrocyte deformability before sevoflurane anesthesia in rats with lower extremity IR. Material and Methods: After approval by the ethics committee, 30 rats were randomly divided into 5 groups. Control (group C), IR (group IR), IR-cerium oxide (group IRCO), IR-sevoflurane (group IRS), IR-cerium oxide-sevoflurane (group IRCOS). Infrarenal abdominal aorta and atraumatic microvascular clamp were placed in IR groups 30 minutes after intraperitoneal cerium oxide was administered at a dose of 0.5 mg / kg. One hundred and twenty minutes later, the clamp was removed and reperfused for 120 minutes. Sevoflurane was applied at a rate of 2.3% at 4 L/min and 100% oxygen during IR for the minimum alveolar concentration to be 1 for rats. All rats were administered intraperitoneal ketamine (100 mg/kg) and euthanasia was performed by taking blood from the abdominal aorta. Erythrocytes were obtained from heparinized whole blood samples. Deformability measurements were made in erythrocyte suspensions in phosphate-buffered saline. A constant flow filtrometer system was used for the measurement of erythrocyte deformability and relative resistance was calculated. Results: Erythrocyte deformability index was found to be significantly different between the groups (p=0.002). Compared to the control group, the erythrocyte deformability index was significantly higher in IR and IRS groups (p<0.0001, p=0.003, respectively). In the IRCO and IRCOS groups, the erythrocyte deformability index was found to decrease significantly compared to the IR group (p=0.008, p=0.025, respectively). The erythrocyte deformability index was similar in Group C and in the IRCO and IRCOS groups (p=0.453, p=0.120, respectively). Discussion: We determined that cerium oxide administered intraperitoneally 30 minutes before ischemia in rats corrects the erythrocyte deformability deteriorated in IR-generated rats. We also found that cerium oxide had beneficial effects by reversing undesirable effects of IR. Further studies with larger volumes are required to support our promising results
引用
收藏
页码:1305 / 1308
页数:4
相关论文
共 50 条
  • [41] Effect of levosimendan on erythrocyte deformability during myocardial ischaemia-reperfusion injury
    Arslan, M.
    Comu, F. M.
    Alkan, M.
    Kiraz, H. A.
    Kip, G.
    Ozer, A.
    Sivgin, V
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2015, 116 (01): : 47 - 50
  • [42] Effects of cerium oxide (CeO2) on liver tissue in liver ischemia-reperfusion injury in rats undergoing desflurane anesthesia
    Huseyin Gobut
    Aysegul Kucuk
    Necmiye Şengel
    Mustafa Arslan
    Cagrı Ozdemir
    Tulay Mortas
    Esat Kasapbası
    Omer Kurtipek
    Mustafa Kavutcu
    [J]. BMC Anesthesiology, 23
  • [43] Protective effect of nitric oxide pathway in resveratrol renal ischemia-reperfusion injury in rats
    Chander, V
    Chopra, K
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2006, 37 (01) : 19 - 26
  • [44] Effect of dexmedetomidine on erythrocyte deformability during ischaemia-reperfusion injury of heart in diabetic rats
    Arslan, M.
    Comu, F. M.
    Kip, G.
    Alkan, M.
    Kiraz, H. A.
    Ozer, A.
    Sivgin, V
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2014, 115 (08): : 494 - 497
  • [45] Effects of halothane, isoflurane and sevoflurane on ischemia-reperfusion injury in the perfused liver of fasted rats
    Imai, M
    Kon, S
    Inaba, H
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1996, 40 (10) : 1242 - 1248
  • [46] Sevoflurane improves renal ischemia-reperfusion injury in rats through RISK signaling pathway
    Wang, Bo
    Yan, Xin
    Zou, Xin
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (08) : 1597 - 1604
  • [47] Ameliorative effect of sevoflurane on endoplasmic reticulum stress mediates cardioprotection against ischemia-reperfusion injury
    Liu, Ai-Jie
    Pang, Chun-Xia
    Liu, Guo-Qiang
    Wang, Shi-Duan
    Chu, Chun-Qin
    Li, Lin-Zhang
    Dong, Yan
    Zhu, De-Zhang
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2019, 97 (05) : 345 - 351
  • [48] Osmundacetone Alleviates Cerebral Ischemia-Reperfusion Injury in Rats
    Li, Bowen
    Yu, Wentao
    Yang, Lan
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2023, 46 (11) : 1527 - 1534
  • [49] Nanoselenium attenuates renal ischemia-reperfusion injury in rats
    Farzaneh Sadeghmanesh
    Akram Eidi
    Pejman Mortazavi
    Shahrbanoo Oryan
    [J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 : 2297 - 2310
  • [50] Nanoselenium attenuates renal ischemia-reperfusion injury in rats
    Sadeghmanesh, Farzaneh
    Eidi, Akram
    Mortazavi, Pejman
    Oryan, Shahrbanoo
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (04) : 2297 - 2310